4.8 Article

Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 133, 期 45, 页码 18280-18288

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ja2064389

关键词

-

资金

  1. National Cancer Institute [5U54CA119347 P.I.]
  2. Institute for Collaborative Biotechnologies (from the U.S. Army Research Office) [W911NF-09-D-0001]
  3. The Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)
  4. Grand Duchy of Luxembourg via Institute for Systems Biology
  5. NRSF [1F32CA136150-01]

向作者/读者索取更多资源

We describe the use of iterative in situ click chemistry to design an Akt-specific branched peptide triligand that is a drop-in replacement for monoclonal antibodies in multiple biochemical assays. Each peptide module in the branched structure makes unique contributions to affinity and/or specificity resulting in a 200 nM affinity ligand that efficiently immunoprecipitates Akt from cancer cell lysates and labels Akt in fixed cells. Our use of a small molecule to preinhibit Akt prior to screening resulted in low micromolar inhibitory potency and an allosteric mode of inhibition, which is evidenced through a series of competitive enzyme kinetic assays. To demonstrate the efficiency and selectivity of the protein-templated in situ click reaction, we developed a novel QPCR-based methodology that enabled a quantitative assessment of its yield. These results point to the potential for iterative in situ click chemistry to generate potent, synthetically accessible antibody replacements with novel inhibitory properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据